DNX-2401
Showing 1 - 10 of 10
Brain Cancer, Brain Tumor, Glioma Trial in Canada, United States (DNX-2401, pembrolizumab)
Completed
- Brain Cancer
- +10 more
- DNX-2401
- pembrolizumab
-
Little Rock, Arkansas
- +14 more
Jul 13, 2021
Liver Metastases, Liver Metastasis Colon Cancer, Colorectal Cancer Trial in Tampa (DNX-2440)
Recruiting
- Liver Metastases
- +10 more
- DNX-2440
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute, Inc.
Mar 28, 2022
Brain Cancer, CNS Diseases Trial in Houston (DNX-2401, Tumor Removal)
Completed
- Brain Cancer
- Central Nervous System Diseases
- DNX-2401
- Tumor Removal
-
Houston, TexasUT MD Anderson Cancer Center
Jul 12, 2018
Glioblastoma or Gliosarcoma Trial in United States (Single intratumoral injection of DNX-2401, Interferon-gamma)
Completed
- Glioblastoma or Gliosarcoma
- Single intratumoral injection of DNX-2401
- Interferon-gamma
-
Tampa, Florida
- +3 more
Jul 12, 2018
Glioblastoma Multiforme, Recurrent Tumor Trial in Pamplona (DNX2401 and Temozolomide)
Completed
- Glioblastoma Multiforme
- Recurrent Tumor
- DNX2401 and Temozolomide
-
Pamplona, Navarra, SpainClinica Universidad de Navarra
Oct 23, 2017
Virus Diseases Trial in Worldwide (Danirixin 15 mg FBE, Danirixin 50 mg FBE, Placebo)
Terminated
- Virus Diseases
- Danirixin 15 mg FBE
- +3 more
-
Stamford, Connecticut
- +7 more
Nov 20, 2020
Glioblastoma, Glioblastoma, Adult Trial in Pamplona (DNX-2440 injection)
Recruiting
- Glioblastoma
- Glioblastoma, Adult
- DNX-2440 injection
-
Pamplona, Navarra, SpainClinica Universidad de Navarra
Jun 23, 2020
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (Danirixin, Danirixin matching , Standard of care)
Completed
- Pulmonary Disease, Chronic Obstructive
- Danirixin
- +3 more
-
Birmingham, Alabama
- +63 more
Oct 6, 2020
Virus Diseases Trial in Australia, South Africa, United States (GSK1325756 (Danirixin), Placebo To Match GSK1325756, Oseltamivir
Completed
- Virus Diseases
- GSK1325756 (Danirixin)
- +3 more
-
Palmetto Bay, Florida
- +32 more
Jul 10, 2019
Leukemia, Myeloid, Acute Trial in Gent (Volasertib)
Withdrawn
- Leukemia, Myeloid, Acute
-
Gent, BelgiumBoehringer Ingelheim Investigational Site
Jan 26, 2017